ABO blood group is associated with response to inhaled nitric oxide in neonates with respiratory failure

• Published in: PloS one 2012-09, Vol.7 (9), p.e45164-e45164
• Main Authors: El-Ferzli, George T, Dreher, Mackenzie, Patel, Rakesh P, Ambalavanan, Namasivayam
• Format: Article
• Language: English
• Subjects: ABO Blood-Group System; ABO system; Administration, Inhalation; Adult; Adults; Antigens; Apgar Score; Biology; Birth Weight; Blood; Blood Gas Analysis; Blood group A; Blood groups; Child; Children; Failure; Female; Free radicals; Genomes; Gestational Age; Humans; Hypertension; Infant; Infant, Newborn; Infants; Male; Medical records; Medicine; Multivariate Analysis; Neonates; Newborn babies; Newborn infants; Nitric oxide; Nitric Oxide - administration & dosage; Nitric Oxide - therapeutic use; Outcome Assessment (Health Care); Oxygen - blood; Oxygen - metabolism; Oxygenation; Pediatrics; Persistent Fetal Circulation Syndrome - blood; Persistent Fetal Circulation Syndrome - diagnosis; Persistent Fetal Circulation Syndrome - drug therapy; Pulmonary hypertension; Respiratory distress syndrome; Respiratory failure; Respiratory Insufficiency - blood; Respiratory Insufficiency - diagnosis; Respiratory Insufficiency - drug therapy; Respiratory therapy; Retrospective Studies; Systematic review; Time Factors; Type 2 diabetes; Ventilators
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0045164

Inhaled nitric oxide (iNO) reduces death or need for extracorporeal membrane oxygenation (ECMO) in infants with persistent pulmonary hypertension of the newborn (PPHN). However, the response to iNO is variable and only 50-60% of infants demonstrate a response to iNO. It is not known why only some infants respond to iNO. Adults and children with blood groups B or AB do not respond as well to iNO as those with blood groups O/A. To determine if blood group was associated with iNO response in newborn infants, a retrospective medical record review was done of infants admitted to a regional NICU from 2002-9 with a diagnosis of PPHN. Data were collected during the first twelve hours post-initiation of treatment. Of 86 infants diagnosed with PPHN, 23 infants had blood group A [18 received iNO], 21 had group B [18 with iNO], 40 had group O [36 with iNO], and 2 had group AB [both received iNO]. Change in PaO(2)/FiO(2) was less in infants with blood group A, of whom less than half were responders (ΔPaO(2)/FiO(2)>20%) at 12 h versus 90% of infants with either O or B. Race, sex, birth weight, gestational age, Apgar scores at 1 and 5 minutes, and baseline PaO(2)/FiO(2) were similar among groups. Outcomes including need for ECMO, death, length of ventilatory support, length of iNO use, and hospital stay were statistically not different by blood groups. Our results indicate that blood group influences iNO response in neonates. We hypothesize that either there is genetic linkage of the ABO gene locus with vasoregulatory genes, or that blood group antigens directly affect vascular reactivity.